Healthcare

UPDATE 4-J&J profit beats forecast, shares rise 2:20pm EDT

* J&J raises 2008 forecast to $4.50 to $4.53 per share Full Article

UPDATE 1-U.S. lawmakers expand probe to Bayer aspirin ads 1:57pm EDT

WASHINGTON, Oct 14 (Reuters) - U.S. Democratic lawmakers are expanding their probe into direct-to-consumer drug advertisements to include Bayer AG's combination aspirin product, according to letters released on Tuesday. Full Article

U.S. lawmakers expand probe to Bayer aspirin ads 1:23pm EDT

More Healthcare Articles

IBt buys two units for initial 5 mln euros 12:02pm EDT

BRUSSELS, Oct 14 (Reuters) - Belgian radiotherapy implant maker International Brachytherapy said on Tuesday that it plans to buy two business units from Germany's Eckert & Ziegler AG for 5 million euros ($6.8 million). Full Article

UPDATE 2-U.S. FDA warns CR Bard about Puerto Rico plant 11:18am EDT

WASHINGTON, Oct 14 (Reuters) - U.S. regulators have told medical device maker C.R. Bard Inc to correct manufacturing problems uncovered during an inspection of a plant in Puerto Rico, a letter released on Tuesday said. Full Article

US FDA warns CR Bard about Puerto Rico plant 10:13am EDT

UPDATE 1-Par Pharma trims generic unit, cuts 190 jobs 8:45am EDT

Oct 14 (Reuters) - Par Pharmaceutical Cos Inc said it was cutting 190 jobs in its generic unit and would reduce research and development expenses by focusing on completing products currently in development. Full Article

UPDATE 1-Boston Sci defends finances as stock fluctuates 8:25am EDT

NEW YORK, Oct 14 (Reuters) - Boston Scientific Corp defended its balance sheet, saying the volatility of the broader markets and its stock price have had "no noticeable effect" on its financial strength or ongoing financial performance. Full Article

FUNDVIEW-Liontrust defensive for now, ready for upswing 8:21am EDT

LONDON, Oct 14 (Reuters) - Defensive drugmakers look set to outperform in the coming months as growth slows, but fund manager Liontrust is also eyeing battered stocks like retailers and investment managers to capitalise when the market recovers. Full Article

UK's NICE turns down Glaxo Tyverb offer 7:14am EDT

LONDON, Oct 14 (Reuters) - Britain's healthcare cost effectiveness watchdog NICE has rebuffed GlaxoSmithKline's latest bid to get its drug Tyverb - for women with advanced breast cancer - into the state health system, the company said on Tuesday. Full Article

Market Update

Wealth Management Summit

Stock bargains abound for the brave 12:28pm EDT

GENEVA (Reuters) - Sharp plunges in share prices have thrown up bargains for those with the stomach to plunge back into volatile markets and deep enough pockets to look past the grim economic outlook, bankers to the wealthy said. Full Article

Even as markets rally, executives fear bear trap

BBVA unit says clients slash hedge fund exposure